Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Relative Risk

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Receiver Operating Characteristic Plot

Receiver Operating Characteristic Plot

A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...

Survival Curves

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...

Hazard Rate

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Development and acceptability of gist-based decision aids for prostate and breast cancer screening: a two-phase qualitative interview study in an online setting.

BMJ open·2026

Same author

Patient Engagement With an Electronic Patient-Reported Outcomes Tool Evaluating Hospital Discharge Readiness After Cancer Surgery.

JCO oncology practice·2026

Same author

Nerve Blocks for Mastectomy with Reconstruction: Reply.

Anesthesiology·2026

Same author

ASO Visual Abstract: Identifying Predictors of Delayed Ambulation After Minimally Invasive Gynecologic Oncology Surgery.

Annals of surgical oncology·2026

Same author

AI model predicts patient outcomes from surgical gestures and provides insights into explainability.

npj digital surgery·2026

Same author

Identifying Predictors of Delayed Ambulation After Minimally Invasive Gynecologic Oncology Surgery.

Annals of surgical oncology·2026

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Using relative utility curves to evaluate risk prediction.

Stuart G Baker¹, Nancy R Cook, Andrew Vickers

¹National Cancer Institute, Bethesda, USA.

Journal of the Royal Statistical Society. Series A, (Statistics in Society)

|January 14, 2010

Summary

This study introduces novel methods for evaluating medical risk prediction models, enhancing decision-making by assessing prediction utility and test thresholds. It aims to improve the accuracy and cost-effectiveness of diagnostic testing in clinical practice.

Related Experiment Videos

Last Updated: Jun 17, 2026

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Area of Science:

Medical Decision Making
Health Informatics
Biostatistics

Background:

Medical decisions heavily rely on risk prediction models.
Accurate evaluation of these models is crucial for effective healthcare.

Purpose of the Study:

To introduce five novel contributions to the evaluation of medical risk prediction models.
To enhance the utility and cost-effectiveness of prediction models in clinical settings.

Main Methods:

Development of the relative utility curve for prediction potential assessment.
Definition of the relevant region for prediction performance.
Introduction of the test threshold for evaluating trade-offs in diagnostic testing.
Evaluation of two-stage prediction strategies to minimize test costs.
Exploration of connections between various prediction performance measures.

Main Results:

The relative utility curve provides a reference-free assessment of prediction potential and sensitivity analysis.
The relevant region defines prediction performance consistent with no-prediction treatment.
The test threshold quantifies the value of a true positive in diagnostic testing.
Two-stage predictions demonstrate potential for reducing overall testing costs.
Established connections among diverse prediction performance metrics.

Conclusions:

The proposed methods offer a comprehensive framework for evaluating risk prediction models.
These advancements can lead to more informed medical decisions and optimized diagnostic strategies.
The application to cardiovascular disease risk highlights the practical utility of these new evaluation tools.